(22.09.2020)
The Urania Puppet Theater, home of Kasperl and Pezi, recently hosted a very special guest: Philipp Heher from LBI Trauma, who performed swabs on the entire crew and tested them in the institute’s COVID testing lab. The actors were thrilled by his performance and Pezi sent many kisses and Pezitaler.
(02.09.2020)
At the upcoming world congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) in Maastricht, the Netherlands, the LBI Trauma will be present as organizer of multiple symposia:
(14.07.2020)
Hundreds of employees ensure that the AUVA trauma centers continue to operate even in times of the pandemic. Their work puts them at increased risk of infection, and it is therefore of utmost importance to maintain a high level of safety regarding COVID-19.
This is where the LBI trauma comes into play. During lockdown, the scientists were sent to work from home, leaving the laboratories empty. Head of the institute Johannes Grillari, and chemist Michaela Stainer, both experts in the field of molecular biology, soon recognized the chance to bring the expertise as well as the equipment to good use and assist the AUVA in the fight against COVID-19. Protocols were established and the highly sought after reagents were obtained. Numerous scientists joined the initiative and volunteered to work in the test laboratory. The University of Applied Sciences Technikum Wien and BOKU Vienna provided advice and assistance.
(08.07.2020)
The LBG is seeking to hire a full-time Research Group Leader (40 hours/week) for the newly established research group “Senescence and Healing of Wounds” (SHoW), which is located at the LBI Trauma, Lorenz Böhler Trauma Center. SHoW aims to investigate the role of senescent cells in skin wounds whose healing progress has been compromised. The research group’s thematic focus is the outcome of an Open Innovation in Science priority setting process conducted by the LBG in collaboration with interested publics. Supported by an Open Innovation in Science approach, the SHoW research group shall work toward clinically relevant outcomes.
(20.06.2020)
MicroRNAs (miRNAs) are short, non-coding RNA fragments that play an integral role in various biological processes by regulating gene expression and protein translation. In bone, miRNAs directly affect osteogenic cell maturation and function, and thus partake in fetal skeletal development and maintenance of postnatal bone health. In a recent study performed by scientists from LBI Trauma and BOKU, they were able to identify a change in microRNA levels associated with PLS3 mutation.
(15.05.2020)
With the S&B Award, the Rudolf Sallinger Fund awards early-stage commercialization ideas based on state-of-the-art research. This year, Johannes Hackethal was nominated for this award with his start up The Human Touch. He is already among the top 10 and on October 6th, the ten nominates are going to pitch their ideas and compete for the big prize. The recipient of the first place will be awarded with € 20,000 as well as mentoring services and other support offers for their commercialization idea. All projects placed 2-10 will receive mentoring services and other support offers for their commercialization idea.
(26.05.2020)
Congratulations to Julia Maier, who just finished her doctoral thesis with distinction at TU Vienna! In course of her thesis, she looked into isolation and ex-vivo activation of adipose-derived cells.
(22.05.2020)
In COVID-19, the world is facing one of the gravest health challenges in modern time. Knowledge of the disease’s pathophysiology is still limited and specific treatments against it virtually non-existent. The quest for answers has led to a growing deluge of information, in lay and scientific press alike.
Scientific articles have been published in record numbers and multiple mechanism-of-action concepts, treatment paradigms and original data regarding SARS-CoV-2/COVID-19 have been spreading at flashing speed. This includes publications that emerge without a proper peer-review scrutiny on the so-called preprint servers. The number of preprints on the bio/medRxiv domain alone has already surpassed 3800. Such a rapid pace of information generation and exchange can quickly become confusing and misleading. Despite the urgency, a thorough scientific analysis is needed to ensure judicious conclusion drawing. After all, new data directly influence the design of clinical trials (currently >1600 registered trials) and subsequently translate into treatment practices in COVID-19 patients.
(13.05.2020)
The Vienna Center for Engineering in Medicine, (VICEM), an inter-university cooperation center between the Technical University of Vienna and the Medical University of Vienna, annually awards a Diploma Thesis Award for an outstanding thesis. This year, the award went to Julia Böhm from LBI Trauma for her work entitled „Extrakorporale Stoßwellentherapie – Simulation elektrohydraulisch erzeugter Stoßwellen und deren Druckfelder bei Gewebeinteraktion“ (Extracorporeal shock wave therapy - simulation of electrohydraulically generated shock waves and their pressure fields during tissue interaction).
(16.04.2020)
Head of the institute, chair of TERMIS Europe, founder of the Austrian Cluster for Tissue Regeneration…. Heinz Redl has achieved a lot in his scientific career - and is far from done yet. In an interview with chemiereport.at he looks back at the greatest successes and gives insights into his fascination with tissue regeneration and the future of trauma research. The article was published in the current issue and is accessible online here (German only).